Hemab Therapeutics

Hemab Therapeutics

Denmark - Copenhagen
Biotechnology

Focus: Bleeding Disorder Treatments

Hemab Therapeutics is a life sciences company focused on Bleeding Disorder Treatments.

Hematology
Funding Stage
SERIES C +
Employees
5000+
Open Jobs
6

Pipeline & Clinical Trials

survey and interview
Glanzmann Thrombasthenia
N/A
Clinical Trials (1)
NCT05315232The Experiences of People Who Live With Glanzmanns Thrombasthenia.
N/A
N/A
Clinical Trials (1)
NCT06064643The Lived Experience of People With Von Willebrand Disease
N/A
Clinical outcomes of patients with VWD, Type 1
Von Willebrand Disease (VWD)
N/A
Clinical Trials (1)
NCT06610201A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
N/A
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Hematologic Disorder
N/A
Clinical Trials (1)
NCT04398628ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
N/A
Comparison of blood samples between the two groups
Leiomyoma, Uterine
N/A
Clinical Trials (1)
NCT05607602Are Uterine Fibroids Pro-thrombotic?
N/A
Phase 1/2
Clinical Trials (1)
NCT06211634A Phase 1/2 Study to Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of HMB-001 in Glanzmann Thrombasthenia
Phase 1/2
Clinical Trials (1)
NCT06754852A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/2
Clinical Trials (1)
NCT07347249A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency
Phase 2

Open Jobs (6)

Interview Prep Quick Facts
Portfolio: 8 clinical trials
Top TAs: Cardiovascular, Hematology, Rare Diseases
Publications: 3 in PubMed
Open Roles: 6 active jobs
Therapeutic Area Focus
Cardiovascular
2 pipeline
Hematology
1 pipeline
Rare Diseases
1 pipeline
Women's Health
1 pipeline
Marketed
Pipeline